Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study.
Sarter H, Crétin T, Savoye G, Fumery M, Leroyer A, Dauchet L, Paupard T, Coevoet H, Wils P, Richard N, Turck D, Ley D, Gower-Rousseau C; EPIMAD study Group. Sarter H, et al. Among authors: leroyer a. Lancet Reg Health Eur. 2024 Oct 18;47:101097. doi: 10.1016/j.lanepe.2024.101097. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39478988 Free PMC article.
Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort.
Dupont-Lucas C, Leroyer A, Ley D, Spyckerelle C, Bertrand V, Turck D, Savoye G, Maunoury V, Guillon N, Fumery M, Sarter H, Gower-Rousseau C; EPIMAD Study Group. Dupont-Lucas C, et al. Among authors: leroyer a. J Crohns Colitis. 2023 Apr 19;17(4):524-534. doi: 10.1093/ecco-jcc/jjac166. J Crohns Colitis. 2023. PMID: 36316987
Natural History of Anal Ulcerations in Pediatric-Onset Crohn's Disease: Long-Term Follow-Up of a Population-Based Study.
Mortreux P, Leroyer A, Dupont C, Ley D, Bertrand V, Spyckerelle C, Guillon N, Wils P, Gower-Rousseau C, Savoye G, Fumery M, Turck D, Siproudhis L, Sarter H. Mortreux P, et al. Among authors: leroyer a. Am J Gastroenterol. 2023 Sep 1;118(9):1671-1678. doi: 10.14309/ajg.0000000000002301. Epub 2023 Apr 25. Am J Gastroenterol. 2023. PMID: 37104674
Incidence and risk factors for thromboembolic events in pediatric-onset inflammatory bowel disease: A French population-based study.
Richard N, Leroyer A, Ley D, Dupont C, Bertrand V, Wils P, Gower-Rousseau C, Turck D, Guillon N, Sarter H, Savoye G, Fumery M; “EPIMAD study group”. Richard N, et al. Among authors: leroyer a. Dig Liver Dis. 2024 Sep 24:S1590-8658(24)01004-1. doi: 10.1016/j.dld.2024.09.005. Online ahead of print. Dig Liver Dis. 2024. PMID: 39322448 Free article.
Rise and fall in medical education research 1999-2019.
Rollin L, Ladner J, Kerdelhué G, Leroyer A, Grosjean J, Gehanno JF. Rollin L, et al. Among authors: leroyer a. Med Teach. 2024 Oct;46(10):1382. doi: 10.1080/0142159X.2024.2371528. Epub 2024 Jul 2. Med Teach. 2024. PMID: 38954529 No abstract available.
Soluble CD146 cooperates with VEGF-A to generate an immunosuppressive microenvironment in CD146-positive tumors: interest of a combined antibody-based therapy.
Joshkon A, Traboulsi W, Terme M, Bachelier R, Fayyad-Kazan H, Dignat-George F, Foucault-Bertaud A, Leroyer AS, Bardin N, Blot-Chabaud M. Joshkon A, et al. Among authors: leroyer as. Mol Cancer Ther. 2024 Oct 21. doi: 10.1158/1535-7163.MCT-24-0008. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39431288
114 results